Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • COP vs GSK✓SelectedUSD · GSKCOP vs GSK performance historyLatest closeAs of-0.59%11/16
Stock and ETF performance explorer

COP vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+331.7%
GSK return
+107.3%
Excess return
+224.4%
Maximum drawdown
-70.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.6%-0.1%-0.5%-0.6%
7D+5.2%-1.3%+6.5%+5.6%
30D-3.5%+2.7%-6.2%-4.5%
3M+12.3%+2.7%+9.6%+10.8%
6M+16.3%+3.3%+13.0%+14.0%
YTD+54.4%+6.5%+48.0%+47.7%
1Y+59.7%+10.7%+49.0%+50.5%
3Y+37.3%+64.4%-27.1%+5.0%
5Y+131.1%+46.7%+84.4%+82.5%
10Y+331.7%+109.4%+222.3%+195.2%
All+331.7%+107.3%+224.4%+195.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling